Stocks / NASDAQ / Flexion Therapeutics, Inc.

Flexion Therapeutics, Inc.

Our Opinion

Flexion Therapeutics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.

“We seek to mitigate development risk by selecting product candidates that have at least demonstrated efficacy in animal models of disease or have validated mechanisms of action.” (Page 4) Read the full document.

Company Description

Flexion Therapeutics, Inc. is a pharmaceutical company focuses on development and commercialization of novel, local therapies. It specializes in treatment of patients with musculoskeletal conditions including osteoarthritis, a type of degenerative arthritis. Its products include Zilretta. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. [Source: MarketWatch]

Company Website: